ACTRN12618001206213已完成未知
asal High Flow Therapy for Infants less than 12 months with Bronchiolitis – Translating new knowledge into practice
ady Cilento Children's Hospital0 个研究点目标入组 235 人开始时间: 2018年7月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 235
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- Months 至 o limit（—）
- 性别
- All
入选标准
- •Inclusion criteria for patients:
- •Infants less than 12 months old with bronchiolitis who are admitted to hospital and have an oxygen requirement with SpO2<92%
- •Inclusion criteria for nurses receiving educational support
- •Registered or Enrolled nurse
- •Current employees of the health care facility
- •Nurses permanently on the roster for the participating ward/ED for the duration of the study.
- •Inclusion criteria for medical staff
- •Residents, Registrars, Fellows and Consultants
- •Current employees of the Health care facility
- •Medical staff who will be on the roster for the participating ward/ED for the duration of the study.
排除标准
- •Exclusion criteria for patients
- •Critically ill with immediate need for NIV/Intubation
- •Apnoeas requiring NIV/ Intubation
- •Blocked nasal passages/choanal atresia
- •Upper airway obstruction
- •Craniofacial malformations
- •Trauma/surgery to nasopharynx
- •Pneumothorax
- •Cyanotic congenital heart disease
- •Decreased level of consciousness
- •Oncology patients
- •Foreign body aspiration- suspected or confirmed
- •Any patient with known lung disease or other conditions that have not been discussed with either the Respiratory Consultant or the treating Paediatrician
- •Exclusion criteria for nursing and medical staff
- •Agency or casual pool nurses
- •Locums (medical)
研究者
相似试验
已完成
不适用
Feasibility and Efficacy of Nasal High Flow in Children post Extubation - Pilot phase studyAirway managementPost extubation respiratory supportRespiratory - Other respiratory disorders / diseasesACTRN12621001678886Gold Coast Hospital and Health Services91
进行中（未招募）
1 期
Traitement précoce de patients pédiatriques présentant un syndrome hémolytique et urémique typique par l’anticorps monoclonal anti-C5 eculizumab : essai thérapeutique prospectif randomisé contrôlé contre placebo de phase IIIHemolytic and uremic syndromeMedDRA version: 17.0 Level: LLT Classification code 10042814 Term: Syndrome hemolytic uremic System Organ Class: 100000004851EUCTR2014-001169-28-FRCentre Hospitalier de Toulouse100
招募中
不适用
Prospective randomised cross-over trial of regional citrate with heparin for anticoagulation and additional albumin prime in continuous venovenous haemofiltration in childreAcute renal failureRenal and Urogenital - Kidney diseaseACTRN12608000462381The Royal Childrens' Hospital Mebourne100
进行中（未招募）
1 期
Extremely low gestational age infants' PARAcetamol StudyOpen ductus arteriosus of a premature infantEUCTR2018-000566-11-FIniversity of Oulu40
已完成
不适用
Lung Ultrasound to Guide Surfactant TherapyRespiratory Distress SyndromeNCT04330443Institut Investigacio Sanitaria Pere Virgili40